Mitigating Copyright Issues in Remote Learning


Remote learning raises important questions related to how copyright protected materials can be used in an online learning environment. One of the more frequent myths that we hear is that copyright law does not apply to a situation because that situation is educational in nature. However, just because a use is educational in nature, does […]

Continue Reading →

Has the Federal Circuit Made It Nearly Impossible to Maintain Genus Claims?

By Blog Staff

A recent denial by the Supreme Court of the United States (SCOTUS) to hear an appeal by Merck’s Idenix Pharmaceuticals LLC (Idenix), leaves unanswered questions regarding the overall validity of genus claims, particularly within the biopharma field. The SCOTUS denied a petition for writ of certiorari to clarify certain Section 112 requirements with respect to […]

Continue Reading →

A Blizzard and a Regulatory Freeze

By Cassie J. Edgar

For those in the Midwest today, I hope you are staying warm & are ready for the predicted snowfall and wind gusts currently in progress. There’s been a lot of news in recent months about agricultural biotechnology regulatory changes underway at various stages of public comment and implementation (7 CFR part 340, proposed EPA rules […]

Continue Reading →

Praised Patent Office Director Resigns

By Kirk M. Hartung

United States Patent and Trademark Office Director Andrei Iancu resigned as director of the agency, receiving high praise from the Chair of the Senate Judiciary Committee’s Subcommittee on Intellectual Property, Thom Tillis (North Carolina).  Senator Tillis told the U.S. Chamber of Commerce on Jan. 19 that Iancu’s leadership was the “gold standard,” and that Iancu […]

Continue Reading →

USPTO Report on Intellectual Property in China: Value, Validity, and Volume

By Sarah M.D. Luth

Last January the U.S. and China signed an Economic Trade Agreement which required China to overhaul its scheme of intellectual property protection. In October of 2020 the National People’s Congress passed new amendments to the Patent Law, which will come into effect on June 1, 2021. The most significant amendments to China’s patent law relate […]

Continue Reading →

Right to Repair: Infringement or Exhaustion Part 2

This post is part 2 of a series of posts relating to a person’s right to repair your purchased products. Part 1 discussed the general background and several policy arguments surrounding both sides of this issue. This post will discuss the main patent laws and legal doctrine related to the right to repair. The central […]

Continue Reading →

Charles P. Romano, Ph.D. Joins McKee, Voorhees & Sease, PLC

By Richard Marsolais

MVS is excited to announce that Charles P. Romano, Ph.D. has joined MVS as a Senior Patent Agent. Charley, who is a registered patent agent, will bring over 30 years of biotech industry experience and doctorate in biochemistry to serve clients in the biotech industry and university sectors. “Charley has worked for Monsanto and in […]

Continue Reading →

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up